Expresión del receptor de factor de crecimiento epidérmico en cáncer de ovario
Pérez Cutiño, Maité; Alonso Remedios, Alain; González Ortega, Elizabeth.
Rev. cuba. obstet. ginecol
; 44(2): 1-11, abr.-jun. 2018. ilus
Artículo en Español | CUMED, LILACS | ID: biblio-1003949
Documentos relacionados
[Salivary gland cancer: new therapeutic approaches].
anti-EGFR capture mitigates EMT- and chemoresistance-associated heterogeneity in a resistance-profiling CTC platform.
Prognostic value of immunohistochemical expression profile of epidermal growth factor receptor in urothelial bladder cancer.
Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
Leukemia stem cell immunophenotyping tool for diagnostic, prognosis, and therapeutics.
Zinc transporter LIV1: A promising cell surface target for triple negative breast cancer.
Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia.
Correlation Between Circulating Tumor DNA Levels and Response to Tyrosine Kinase Inhibitors (TKI) Treatment in Non-Small Cell Lung Cancer.
Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway.
Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer.